학술논문
820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells
Document Type
article
Author
Jing Zhou; Mark Throsby; Lex Bakker; Arpita Mondal; Wilfred Marissen; Paul Tacken; Steef Engels; Liang-Chuan Wang; Patrick Mayes; Cecile Geuijen; Rinse Klooster; Pieter Fokko Van Loo; Yao-Bin Liu; Arjen Kramer; Thomas Condamine; Alla Volgina; Linda Hendriks; Hans van der Maaden; Eric Rovers; Floris Fransen; Renate den Blanken-Smit; Vanessa Zondag-van der Zande; Abdul Basmeleh; Willem Bartelink; Ashwini Kulkarni; Cheng-Yen Huang; Leslie Hall; Shane Harvey; Chrysi Kanellopoulou; Shaun Stewart; Horacio Nastri; Ton Logtenberg; Simon Plyte
Source
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Subject
Language
English
ISSN
2051-1426